STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349649]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
  
 
STAR Caregivers – Virtual Training and Follow -up 
 
Grant Number:  1 R01AG061926 -01 
 
Principal Investigator:  [INVESTIGATOR_286705], PhD  
 
Version Number:  V4 
[ADDRESS_349650]  2024 
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349651]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 
 
SIGNATURE [CONTACT_286732] s constitut ing approval of this protocol and the attachments and provid ing necessary 
assurances that this trial will be conducted according to all stipulations of the protocol, including all 
statements regarding confidentiality, and according to local legal and regulatory requirements and 
applicable U .S. federal regulations and guidelines . 
 
Signatories for this protocol are:  
 
 
_____________________________________  
Robert Penfold, PhD – Principal Investigator  
[INVESTIGATOR_286706] – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349652] OF ABBREVIATIONS  ................................ ................................ ................................ .....................  6 
PROTOCOL SUMMARY – SUAY PRAGMATIC EFFECTIVENESS TRIAL  ................................ ......................  [ADDRESS_349653] INFORMATION  ................................ ................................ ..................  8 
2 INTRODUCTION: BACKGROUND INFORMATION AND SCIENTIFIC RATIONALE  ..............................  9 
2.1 Background Information  ................................ ................................ ................................ ........  9 
2.2 Rationale and Objectives  ................................ ................................ ................................ .......  9 
3 OUTCOME MEASURES  ................................ ................................ ................................ .............  11 
3.1 Primary Outcomes  ................................ ................................ ................................ ...............  11 
3.2 Secondary Outcomes  ................................ ................................ ................................ ...........  11 
4 TRIAL DESIGN  ................................ ................................ ................................ .........................  13 
5 STUDY ENROLLMENT AND WITHDRAWAL  ................................ ................................ ................  14 
5.1 Inclusion and Exclusion Criteria for Persons Living with Dementia  ................................ ..... 14 
5.2 Inclusion and Exclusion Criteria for Caregiver Subjects  ................................ .......................  14 
5.3 Randomization Assignment Procedures  ................................ ................................ ..............  15 
5.3.1  Randomization Procedures  ................................ ................................ .....................  15 
5.3.2  Blinding  ................................ ................................ ................................ ...................  15 
5.4 Withdrawal  ................................ ................................ ................................ ...........................  15 
5.5 Control arm  ................................ ................................ ................................ ..........................  15 
6 INTERVENTION ARM  ................................ ................................ ................................ ...............  16 
6.1 Intervention Arm  ................................ ................................ ................................ ..................  16 
6.2 Eligibility Confirmation  ................................ ................................ ................................ .........  16 
6.3 Consent  ................................ ................................ ................................ ................................  17 
6.3.1  Verbal Consent for screening questions  ................................ ................................ . 17 
6.3.2  Verbal Consent for participation in study  ................................ ...............................  18 
6.3.3  Caregiver is not the DPOA or Priority Person  ................................ .........................  18 
6.4 Orientation Call  ................................ ................................ ................................ ....................  19 
6.4.1  Intervention Arm only  ................................ ................................ .............................  19 
6.5 Online Learning Modules  ................................ ................................ ................................ ..... 19 
6.6 Weekly Coach Phone Calls  ................................ ................................ ................................ ... 20 
6.7 Secure Messaging (Email in the patient portal)  ................................ ................................ ... 20 
6.8 Procedures for Training Study Coaches and Fidelity Monitoring  ................................ ........  20 
7 STATISTICAL CONSIDERATIONS ................................ ................................ ................................  21 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349654]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 7.1 Sample Size Considerations  ................................ ................................ ................................ . 21 
7.1.1  Statistical Power for Primary Outcome. ................................ ................................ .. 21 
7.2 Analysis Plan  ................................ ................................ ................................ .........................  21 
7.2.1  Statistical Analysis Plan  ................................ ................................ ...........................  21 
7.2.2  Aim 1. Feasibility/Acceptability  ................................ ................................ ...............  21 
7.2.3  Feasibility/Acceptability - Completion of Training.  ................................ .................  [ADDRESS_349655] of STAR -VTF on CG burden and PLWD antipsychotic medication use. .........  22 
7.2.7  Caregiver depression, stress and self -efficacy.  ................................ .......................  22 
7.3 Handling of Missing Data  ................................ ................................ ................................ ..... 23 
8 PRAGMATIC TRIAL OVERSIGHT  ................................ ................................ ................................  24 
8.1 Data Safety Monitoring by [CONTACT_286719]  ................................ ................................ ............  24 
9 QUALITY CONTROL AND QUALITY ASSURANCE  ................................ ................................ ........  25 
9.1 Study Procedures  ................................ ................................ ................................ .................  25 
9.2 Protocol Deviations  ................................ ................................ ................................ ..............  25 
10 ETHICS/PROTECTION OF HUMAN SUBJECTS  ................................ ................................ .............  [ADDRESS_349656] KEEPI[INVESTIGATOR_1645]  ................................ ................................ .................  28 
11.1  Data Management Responsibilities  ................................ ................................ .....................  28 
11.2  Data Capture Methods  ................................ ................................ ................................ .........  28 
11.3  Study Records Retention  ................................ ................................ ................................ ...... 28 
12 DATA SHARING PLAN  ................................ ................................ ................................ ..............  29 
12.1  Data Sharing Experience  ................................ ................................ ................................ ...... 29 
12.2  Data and Resource Sharing Plan  ................................ ................................ ..........................  29 
12.2.1  Access - STAR -VTF Repository and Data Sharing Capacity  ................................ ...... 29 
12.2.2  Timetable for Data Release  ................................ ................................ .....................  30 
12.2.3  Restrictions to Data Sharing  ................................ ................................ ....................  30 
12.2.4  Data Deidentification Procedures  ................................ ................................ ...........  30 
12.2.5  Data Curation and Documentation  ................................ ................................ .........  31 
12.3  Data Sharing Summary  ................................ ................................ ................................ .........  31 
13 REFERENCES  ................................ ................................ ................................ ...........................  32 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349657]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349658]  Alzheimer’s Disease and Related Dementias  
BPSD  Behavioral and Psychological Symptoms of Dementia  
CG Caregiver  
CMS  Caregiver Master Scale  
DPOA  Durable Power of Attorney  
DSRS  Dementia Severity Rating Scale  
EHR Electronic Health Record  
FAQ  Functional Activities Questionnaire  
GAD  [ADDRESS_349659]  
KPWA  Kaiser Permanente Washington  
KPWHRI  Kaiser Permanente Washington Health Research Institute  
LAR Legally Authorized Representative  
MHRN  Mental Health Research Network  
NACDA  National Archive of Computerized Data on Aging  
NIA National Institute on Aging  
PHQ8  8-item Patient Health Questionnaire  
PLWD  Person Living With Dementia  
REDCap  Research Electronic Data Capture [software]  
RMPBC  Revised Memory and Problem Behavior Checklist  
SFT Secure File Transfer  
STAR -VTF Staff Training in Assisted living Residences – Virtual Training and 
Follow -up 
 
 
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349660]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 PROTOCOL SUMMARY  – SUAY PRAGMATIC EFFECTIVENESS TRIAL  
Title:  STAR Caregivers – Virtual Training and Follow -up 
Précis: The STAR -Caregivers program is an education, training, and support 
intervention demonstrated efficacious in reducing the behavioral and 
psychological symptoms of dementia. The investigators propose to test a 6 -
session, self -directed, online version called STAR -virtual training and follow -up 
(STAR -VTF) that leverages secure email within the member portal at Kaiser 
Permanente Washington, an online learning management system, and [ADDRESS_349661] of the program. Outcomes in the 
intervention arm will be compared to an attention control group that receives 
printed materials and links to online training resources but does not receive 
coaching.  
Objectives:  Test the effectiveness of the intervention training vs. attention control in a 
practical clinical trial involving one hundred caregiver -person living with 
dementia dyads at Kaiser Permanente Washington.  
Population s:  Persons living with dementia and their informal caregivers  (spouses and adult 
children)  
Site:  Kaiser Permanente Washington  
Description of 
Intervention:  This study evaluates the effectiveness of a caregiver outreach, self -directed 
online training, and support program for caregivers of people with dementia 
who are using an antipsychotic medication to manage agitation/aggression. 
The Investigators will conduct a randomized trial of the caregiver program 
compared to a control group to measure differences in caregiver burden and 
discontinuation of antipsychotic medication use. The results will help in 
expanding access to and delivery of empi[INVESTIGATOR_286707].  
Trial Duration:  [ADDRESS_349662] 
Participation 
Duration:  6 months  
Estimated Time to 
Complete 
Enrollment:  12 months  
  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349663] INFORMATION  
Principal Investigator :   [INVESTIGATOR_286705], PhD , Scientific Investigator  III 
Kaiser Permanente Washington Health Research Institute  (KPWHRI)  
[ADDRESS_349664]  
Seattle, WA [ZIP_CODE]  
[EMAIL_5608]  
(206) 287 -2232  
Program Director :   Lisa Onken, NIA  
Institutions:  Kaiser Permanente Washington   
University of Washington  
Co-Investigators : Linda Teri, PhD, University of Washington  
Susan McCurry, PhD, University of Washington  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349665]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 2 INTRODUCTION : BACKGROUND INFORMATION  AND SCIENTIFIC RATIONALE   
2.1 Background Information  
Alzheimer’s Disease and related dementias (ADRD) are debilitating conditions affecting more than 5 
million Americans in 2014. (1, 2)  With aging of the population it is projected that 8.[ADDRESS_349666] over the next 15 years (3, 4)  and health care costs attributable to ADRD are 
projected to be more than 1.2 trillion by 2050. (2) Behavioral and Psychological Symptoms of Dementia 
(BPSD) (anxiety, agitation, depression) are common and often involve aggressive behavior towards 
family caregivers (CG) in response to unmet needs, discomfort, or frustration. BPSD are disturbing and 
frequ ently lead to CG seeking medication to control patient symptoms. Antipsychotic use in persons 
living with dementia (P LWD) more than doubles mortality risk; (5) however, many caregivers are willing 
to accept those risks. The Choosing Wisely Guidelines from the American Psychiatric Association (6) and 
American Geriatrics Society (7) both recommend against prescribing antipsychotics as a first -line 
treatment for BPSD. STAR -Caregivers is an efficacious first -line behavioral treatment, endorsed by [CONTACT_286720], (8) that involves caregiver training to manage BPSD. (9-16) However, the 
program has not been implemented widely – partly due to the cost of the programs, (17) difficulty 
conducting outreach, (18, 19)  and modality of training (in person with written materials). Adequate 
caregiver training and commensurate reduction in caregiver burden are the mediators (mechanisms) we 
will engage in this Stage III trial to reduce BPSD and discontinue antipsychotic medi cation use by P LWD.  
 
2.2 Rationale  and Objectives  
The STAR -Caregivers program is an education, training, and support intervention demonstrated 
efficacious in reducing BPSD. (9, 10, 20, 21)  The original program involved 8 face -to-face, in -home 
training sessions and 4 follow -up phone calls. The condensed version involves 4 in -home sessions with 2 
phone follow -ups.(18) Neither of these is feasible from a payer perspective due to the cost and, more 
recently, the COVID -[ADDRESS_349667] a self -directed, online version 
called STAR -virtual training and follow -up (STAR -VTF) that leverages week ly telephone calls and secure 
email within the member portal at Kaiser Permanente Washington to improve access to training, fidelity 
to the STAR principles, and to lower the cost of the program.  
 
This trial will ascertain the feasibility and acceptability of STAR -VTF in which (a) caregiver training 
materials are delivered electronically and learning is self -directed, (b) caregivers have 7 telephone calls 
with a social worker and (c) where caregiver s receive ongoing support from a social worker via secure 
messaging in the web -based portal (My Kaiser Permanente). We will compare outcomes in the STAR -VTF 
group to an attention control group that receives mailed material from the Alzheimer’s Association and 
National Institute of Mental Health plus generic secure messages. Our specific aims are:  
AIM 1 : Assess the feasibility and acceptability of conducting caregiver outreach, training, and support via 
social workers and licensed mental health counselors including: (1) willingness of caregivers to interact 
through secure messaging (contact [INVESTIGATOR_4026]) and te lephone; and (2) willingness of caregivers to complete 
self-directed training (training completion rates).  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349668]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 AIM2 : Assess the feasibility and acceptability of the program from the payer perspective including: (1) 
average time spent per orientation visit; (2) average time per month spent responding to caregiver 
emails and coordinating care with primary care physicians ; and (3 differences in face -to-face primary 
care, urgent care, and emergency department visit rates by [CONTACT_286721].  
AIM 3 : Test the hypotheses that (H1) caregiver participants in STAR -VTF will have lower levels of 
caregiver burden at 8 weeks and 6 months compared to an attention control group; and (H2) P LWD 
participants in STAR -VTF will have lower rates of antipsychotic medication use at 6 months compared to 
control. Secondary outcomes are: caregiver  depression , caregiver stress and caregiver  self-efficacy. We 
propose to recruit 100 CG -PLWD  dyads (50 per arm).  
This will be the first study to test a low intensity, self -directed caregiver training program with remote 
support from social workers. It will also be the first study to measure changes in antipsychotic 
medication use by P LWD after CG training. Kaiser Permanente is an ideal setting because we have access 
to the complete EHR, prescription medication use, health care use, and demographic data. We will be 
able to identify and enroll participants in real -time using an automated data algorithm as we have done 
previously. (22) This study will be an important step in expanding access to training and support in a 
format that could be implemented within integrated delivery systems with capi[INVESTIGATOR_286708] (i.e., 
Accountable Care Organizations). Growing use of EHR portals in these o rganizations will further increase 
demand for web -based care management/support. Demand will also increase as today’s near -retirees, 
familiar with web -based applications, develop ADRD. Kaiser Permanente has pi[INVESTIGATOR_286709] e Mental Health Research Network (MHRN). Findings from this study will inform a 
future multi -site pragmatic trial across the 13 health systems and 12 million enrollees in the MHRN.  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349669]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 3 OUTCOME MEASURES  
Outcome measures will be collected regardless of the extent to which intervention  arm caregivers  or 
families accepted or utilized interventional components . That is, we will follow an intent -to-treat 
approach  and encouragement trial methods . 
3.1 Primary  Outcomes  
The following primary quantitative outcome measures for the trial will be assessed  for the grant  
deliverable s: 
(1) Change in caregiver burden at [ADDRESS_349670] 
(RMBPC) questionnaire.  The range in subscale scores is 0 to 32 with higher scores representing a 
worse outcome.  
3.2 Secondary  Outcomes  
The following secondary outcome measures for the trial will be assessed:  
(1) Antipsychotic medication Use . Proportion of participants will at least one antipsychotic prescription 
refill after initial medication dispensing, using automated system pharmacy data.  
(2) Change in caregiver depression . Self-reported caregiver depression assessed by [CONTACT_941] 8 -item Patient 
Health Questionnaire (PHQ -8). The PHQ -[ADDRESS_349671] two weeks. The total sum of the 8 responses from the PHQ -8 ranges 
between  0 and 24 with higher scores indicating worse outcome. In general, a total of 10 or above is 
suggestive of the presence of depression.  
(3) Change in caregiver self -efficacy . Self -reported caregiver self -efficacy assessed by [CONTACT_286722]. Total scores can range from 7 to 35, with higher scores reflecting greater caregiver 
mastery. The Caregiver Mastery Scale is a 7 -item measure of self -efficacy. is a 7 -item sel f-report 
scale, indicating the extent to which respondents agree (5) or disagree (1) with each item. Three 
items with negative statements are reverse -scored. Total scores can range from 7 to 35, with higher 
scores reflectin g greater caregiver mastery.  
(4) Change in caregiver stress . Caregiver stress will be measured on the Kingston Caregiver Stress Scale. 
This is a 10 -item measure with respondents rating the level of stress between 1 (copi[INVESTIGATOR_286710], no 
stress) to 5 (extreme stress, feeling at the end of rope). Total scores vary betwee n 10 and 50.  
(5) Response rates for baseline, 8-week, and 6 -month measures . We will assess participants’ 
willingness to complete study measures using the REDCap online survey by [CONTACT_286723].  
(6) Training Completion rate . We will report training completion rates as a measure of feasibility. 
Completion will be defined as viewing all [ADDRESS_349672] one secure message to a study coach in the baseline to 8 -
week period and one message in weeks 9 through 24.  
(7) Primary care visit rates . Measured as the number of primary care visits per eligible study participant 
during the study period.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349673]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 (8) Urgent care visit rates . Measured as the number of urgent care visits per eligible study participant 
during the study period.  
(9) Emergency department visit rates . Measured as the number of emergency department  care visits 
per eligible study participant during the study period.  
(10) Case management time . We will estimate the time spent responding to ad hoc secure messages and 
phone calls by [CONTACT_286724] a payer 
perspective.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349674] a parallel, two-arm pragmatic  clinical trial comparing the intervention and attention 
control groups . The follow up period  for the trial will be 6 months.   
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349675] (EHR) 
data on a weekly basis.  
Because we will enroll dyads, there are inclusion/exclusion criteria for both  persons living with dementia 
and their caregivers . 
Persons with dementia inclusion criteria:  
• Aged ≥ 65 years  
• Diagnosis of Alzheimer's Disease or related dementia (ADRD)  
• Expected to live >= 6 months from enrollment  
Persons with dementia exclusion criteria:  
• A diagnosis of bipolar disorder or schizophreniform disorder  
• The primary care physician's opi[INVESTIGATOR_286711] 6 months.  
• Primary language is not English (patient requires a translator).  
5.[ADDRESS_349676].  
Caregiver inclusion criteria:  
• Aged ≥ 21 years  
• Lives with person with dementia or within 8 miles  
• Provides at least 8 hours of care per week  
Caregiver exclusion criteria:  
• Diagnosis of Alzheimer's Disease or related disorders.  
• Caregiver is not the spouse or adult child of the person living with dementia  
• Primary language is not English  (caregiver requires a translator) . 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349677]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 5.3 Randomization Assignment Procedures  
5.3.1 Randomization Procedures   
The study biostatistician will create a randomization schedule and this will be uploaded into a REDCap 
database . Caregivers who remain eligible for the study after screening will be randomized within 
REDCap following the pre -set randomization schedule.  All eligible caregiver -patient dyads  will be block 
randomized to ensure comparable numbers of dyads  enrolled in each study arm. Caregivers  will be 
categorized according to  age (<75 years, >=75 years), sex, and spouse/non -spouse . 
R, an open -source statistical computing software, will be used to generate an even number of control 
and intervention assignments within each block.  
5.3.[ADDRESS_349678] the consent process 
and orient participants to the printed and online materials available from the Alzheimer’s Association.  
The PI [INVESTIGATOR_286712] -up is complete. Only the study biostatistician , 
programmer , and project manager  will be un -blinded to arm when preparing reports for the Safety 
Officer . The PI  [INVESTIGATOR_286713] -blinded for report ing any serious adverse events or incidental death s to the 
Safety Officer and NIA staff , should such events occur during the course of the trial .  
5.4 Withdrawal  
Caregivers are free to withdraw from study activities at any time. However, we will still measure 
antipsychotic medication utilization rates between intervention and control. A waiver of consent to 
access PLWD  medical records after withdrawal will be obtained.  
5.5 Control  arm 
We will use an attention control arm. P LWD-Caregiver dyads randomized to the control arm will receive 
paper -based information from the Alzheimer’s Association and National Institute on Aging including 
links to online training resources. Control arm participants will also receive 3 scripted secure messages 
(one at 4 weeks , one at 8 weeks  and one at 6 months  following randomization ) to remind them to read 
the provided materials , check the provided web links to training resources , and check in with their 
primary care physician if they have concerns about the PLWD . 
 
.  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349679]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 6 INTERVENTION ARM  
6.1 Intervention Arm  
Randomized PLWD -CG dyads are offered :  
• A telephone orientation visit with a study coach to acquaint the caregiver to the 6 -
session STAR -VTF program and online learning environment.  
• A paper -based and electronic manual to identify priority behaviors, develop plans for 
addressing behaviors, and make plans for pleasant events.  
• 6 weekly telephone coaching visits lasting 30 minutes and corresponding to each of the 
6 training modules.  
• Secure message (email) support within the patient portal, as needed, with the coach to 
help with personalizing the STAR -VTF curriculum for up to 6 months, as initiated by [CONTACT_286725].  
We anticipate that self -directed caregiver training with support from social workers will enhance 
caregivers’ sense of competence and self -efficacy. Training caregivers on good communication and the 
ABCs of dementia problem -solving will lead to decreased a ctivation of behavioral triggers, lower 
incidence of problem behaviors, and lower caregiver stress in response to behaviors. Assisting caregivers 
to engage in higher levels of pleasant activities will enhance PLWD  and caregiver mood and create a 
more posit ive care environment.  With increased insight into the natural disease history, caregivers will 
be able to reframe behaviors as symptoms of dementia rather than insensitivity, rudeness, or deliberate 
provocation. We hypothesize that changes in the physical  and psychosocial environment that reduce 
triggering events and improve caregiver -PLWD dyadic interactions will reduce the need for and use of 
antipsychotic medication.  
 
6.2 Eligibility Confirmation  
Once a PLWD is identified using the automated algorithm, a REDCap  database is populated with the 
potential participants once per week. There are three  steps to confirming eligibility.  
• A study staff person will review the PLWD medical record to confirm that the person has a 
diagnosis of ADRD, an emergency contact [CONTACT_286726]/friend is listed in the record, and that 
the PLWD does not live in an adult family home, skilled nursing facil ity, or memory facility.  
• If eligible after medical record review, the staff person will contact a study coach (clinician) who 
will send a staff message within the EHR to the physician who prescribed the antipsychotic 
medication to the PLWD. The prescribing clinician will be asked:  
o Is [PLWD] capable of making health care decisions for themselves? 
[YES/NO/SOMETIMES]  
o Do you believe [PLWD] will live at least 6 months from today? [YES/NO]  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349680]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 o Was [antipsychotic medication] prescribed for behavioral/psychological symptoms of 
dementia? [YES/NO]  
o Is there any other reason to NOT invite this patient and family caregiver to be in the 
research study? [YES/NO]  
Recruitment will not proceed without a response to these questions by [CONTACT_172189].  
In the third stage, a study staff person will mail an invitation letter to the PLWD -CG dyad. This is 
followed by a screening phone call approximately 3 business days later. The purpose of the screening 
call is to determine:  
• Willingness to take part in the study regardless of the randomization group.  
• Ability to read and speak English.  
• Determine whether the CG has ever been diagnosed with Alzheimer’s disease or related 
dementia  
• Confirm the PLWD does not live in an adult family home, assisted living facility, skilled nursing 
facility, or memory facility.  
• Whether the caregiver is 21 years or older.  
• Whether the caregiver lives in the same household as the PLWD or within 8 miles (30 minutes).  
• Whether the caregiver spends at least 8 hours providing care to the PLWD  
• Whether the caregiver is the DPOA  and if not who that person is.  
• Whether the caregiver is the spouse or adult child of the PLWD  
• Caregiver a ccess to a computer or other device where the caregiver can access the patient 
portal, personal email and websites to complete the online training.  
• Whether the caregiver uses MyChart – the Kaiser Permanente patient portal  - to email the 
doctors that care for the PLWD  
• Administer the Short Portable Mental Status Questionnaire to the caregiver.  
 
If the PLWD -CG dyad remains eligible after the [ADDRESS_349681] information of the person who is DPOA. If the dyad is otherwise eligible, the DPOA will be 
contact[CONTACT_286727].  
6.3 Consent  
6.3.1 Verbal Consent for screening questions  
Following the recruitment packet mailing, two things may happen:  
1.  Potential participants may call our study line and express interest in participating or decline to 
participate. Those expressing an interest will receive a phone call from a Research Specialist and those 
who decline to participate will be coded as such  and not contact[INVESTIGATOR_530].  
2. If we have not heard from the potential caregiver participant, we will follow -up with a phone 
call to assess interest and eligibility.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349682] the DPOA/LAR, describe the study in detail, 
and answer any questions. The study staff member will get verbal consent from the DPOA  or legally 
author ized representative ( LAR) for the P LWD to participate. The study staff member will mail a copy of 
the consent form to the DPOA/LAR following the phone call. If the DPOA /LAR  gives verbal consent for 
the P LWD to participate, study staff will then call the caregiver to schedule the orientation phone visit. 
The purpose of this is to avoid scheduling a phone visit and randomizing a dyad should  the DPOA not 
give consent for the P LWD to participate.  
The consent process will vary depending on the following factors:  
(1) The PLWD  is able to consent for themselves. The PLWD ’s provider will inform the study coach as 
to his/her medical opi[INVESTIGATOR_286714] ’s incompetence (the provider’s response to this 
question is required in order for the PLWD  and caregiver to participate).  
(2) The PLWD  is not able to consent for themselves and the caregiver IS either the DPOA or the 
priority person authorized to make decisions on the PLWD s behalf.  
(3) The PLWD  is not able to consent for themselves and the caregiver is not the DPOA or the 
priority person authorized to make decisions on the PLWD s behalf.  
Under Case #1, the PLWD gives consent on their own behalf. Under case #2, the caregiver gives verbal 
consent on behalf of the PLWD. If possible, we will get verbal assent from the PLWD  as well. Under case 
#3, prior to the visit study staff will speak with the DPOA or the priority person authorized to make 
decisions on behalf of the PLWD and get verbal consent for the PLWD to participate in the study. A copy 
of the consent form will be m ailed to the DPOA or priority person for their records.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349683]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 6.4 Orientation Call  
The purpose of the orientation telephone call is to:  
• Make introductions  
• Review consent forms and obtain informed consent  
• Orient the caregiver to the baseline measures survey site (online) and confirm their ability to 
login  and complete the baseline measure survey  
• Confirm the caregiver has received the printed materials corresponding to their study arm  
6.4.[ADDRESS_349684] the caregiver to:  
• Navigate to the Kaiser Permanente School learning modules site  
• Login using their credentials  
• Give an overview of the learning modules, the cadence of completion (one per week), and 
required homework  
• Schedule the first [ADDRESS_349685] of text, figures and audio describing the principles of the STAR Caregivers program. The modules 
are: 
(1) Introduction to STAR -Caregivers , Overview of Dementia, Principles of Communication  
(2) ABCs of Problem Solving  
(3) Review of ABCs and Modifying Plans  
(4) Pleasant Events  
(5) Review of Pleasant Events, ABCs, Practical Communication  
(6) Pleasant Events for Caregivers  
Each module takes between 30 and 45 minutes to complete  and participants are expected to complete 
one module per week. Participants complete the homework and reading assignments following 
completion of each module. Study coaches review problem solving plans, pleasant events schedules and 
any questions about the material or individual needs during follow -up phone calls.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349686], realistic expectations for PLWD behavior, practical communication, how to 
complete/revise ABC problem solving plans, how to c omplete/revise the pleasant events schedule, and 
how to obtain formal and informal respi[INVESTIGATOR_286715].  
6.7 Secure Messaging (Email in the patient portal)  
Caregivers will be invited to communicate with their coach via email at the completion of the 6-week  
training program and up to the end of the 6-month  follow -up period. Coaches will only respond to 
messages initiated by [CONTACT_50633]. Telephone support will be given only as necessary.  
6.[ADDRESS_349687] quality control will be assured through a sample of in -person observed sessions 
overseen by [CONTACT_6283]. Teri and McCurry.    
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349688]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 7 STATISTICAL  CONSIDERATIONS  
7.1 Sample Size Considerations  
We anticipate enrolling 100 PLWD -CG dyads  in the trial (50 per arm) , with up to 90 remaining enrolled at 
6 months of follow -up (i.e., 10% lost to follow -up).  
7.1.[ADDRESS_349689] of STAR -C on the Subjective Caregiver Burden scale (d=0.77) 
and the Revised Memory and Behavior Problem Checklist (d=0.68) based on the p -values reported for t -
tests comparing the STAR -C mean with the routine medic al care group mean in prior research. We will 
power on the RMBPC (primary outcome) and assume a loss of effect size due to the lower intensity of 
the intervention. Assuming an effect size of 0.65, type -I error of 0.05, power of 80%, and equal sample 
sizes,  we will require 39 dyads in the STAR -VTF arm and 39 dyads in the control arm (n=78). We 
additionally assume it will be necessary to adjust for baseline covariate imbalance and sample attrition, 
thus, we will inflate our recruitment targets by 30% as we ha ve done in the past. The final recruitment 
target will be [ADDRESS_349690] tracking systems , the Epic EMR , and other health system data 
systems  for analysis. Baseline, 8 week, and 6 month measures will be collected via an online survey 
using REDCap functionality.  
Data validation and quality assurance checks will be undertaken to ensure data collection during the 
study is sufficiently reliable.  
7.2.1 Statistical Analysis Plan  
All analyses will be conducted under intention -to-treat principles.  
 
7.2.2 Aim 1. Feasibility/Acceptability  
We will measure response rates for follow -up data collection using the online survey functionality in 
REDCap. We will use descriptive statistics to characterize response rates by [CONTACT_286728].  We will use generalized estimatin g equations (GEE) with a working correlation matrix to 
estimate a logistic regression model for response vs. non -response. We will estimate separate models 
for the 8 -week and 24 -week outcome periods. Models will be adjusted for PLWD stage of dementia 
(DSRS ), PLWD FAQ score, PLWD age and sex, caregiver relationship (spouse, non -spouse), caregiver age 
and sex, caregiver highest level of education attained, PLWD residential status (living with caregiver full -
time versus not) and study arm.  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349691]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 7.2.3 Feasibility/Acceptability - Completion of Training.  
We will use descriptive statistics to characterize completion rates by [CONTACT_286728]. We will use generalized estimating equations (GEE) with a working correlation matrix to 
estimate a logistic regression model for completion vs . non -completion. Models will be adjusted for 
PLWD stage of dementia (DSRS), PLWD FAQ score, PLWD age and sex, caregiver relationship (spouse, 
non-spouse), caregiver age and sex, and caregiver highest level of education attained, and study arm.  
 
7.2.4 Assess the feasibility and acceptability from the payer perspective.  
We will use descriptive statistics to characterize the effort required by [CONTACT_286729]. These measures are (1) time reading secure messages, (2) number of exchanges per message 
thread, (3) number of ad hoc phone calls required  (i.e., other than the 6 scheduled calls).  
 
7.2.5 Primary Care, Urgent Care and Emergency Department Use.  
We will use longitudinal, generalized estimating equations (GEE) to estimate a Poisson regression model 
for adjusted mean monthly visit rates (separately by [CONTACT_166291]) in the STAR -VTF arm compared to the 
attention control arm in the  6 months following ra ndomization. Models will be adjusted for P LWD stage 
of dementia (DSRS), P LWD FAQ score, P LWD age and sex, caregiver relationship (spouse, non -spouse), 
caregiver age and sex, and caregiver highest level of education attained, and study arm. We will use the 
robust sandwich estimator to calculate standard errors to account for repeated (i.e. 6 monthly) 
observations within people and the misspecified variance in the Poisson model.  
  
7.2.[ADDRESS_349692] 
(RMPBC ). We will use GEE with a working correlation matrix to estimate the regression model, using 
robust sandwich estimators to calculate standard errors accounting for within person correlation. We 
will adjust for baseline pre -randomization covariates: P LWD stage of dementia (DSRS), P LWD FAQ score, 
PLWD age and sex, caregiver relationship (spouse, non -spouse), caregiver age and sex, and caregiver 
highest level  of education attained.  
We will use generalized estimating equations (GEE) with a working correlation matrix to estimate a 
logistic regression model for refill (versus no refill) of the initial antipsychotic medication. Models will be 
adjusted for P LWD stage of dementia (DSRS), PLWD  FAQ score, P LWD age and sex, caregiver relationship 
(spouse, non -spouse), caregiver age and sex, and caregiver highest level of education attained, study 
arm. We will again use GEE with a working correlation matrix to estimate a logistic regression mod el for 
daily versus “less than daily” use of antipsychotic medication (as reported to the coach ). Models will 
again be adjusted for pre -randomization variables list ed above.  
7.2.7 Caregiver depression , stress and self-efficacy.  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349693] data on 
all study participants. If there are substantial missing data or significant loss -to-follow -up, we will use 
inverse probability weighting (23) to rebalance the STAR -VTF and attention control group. Inverse 
probability weights are used to rebalance groups on prognostic factors when the treatment and control 
groups become unbalanced over time, post -randomization, due to study drop out. If we find 
intermittent missing data, we will instead use multiple imputation (24) via chained equations to address 
the problem, using at least 10 imputed datasets and combining results using Rubin’s rules.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349694] as the Safety Officer for the Phase 3 pragmatic trial.  
The Safety Officer and PI [INVESTIGATOR_286716] A of its findings  and r eports will be shared with the KPWHRI IRB, 
as required . We will be responsive to additional specific requests for data reports that may be requested 
by [CONTACT_286730] .   
Confidentiality will be maintained during all phases of review and deliberations.   
A separate data safety monitoring plan accompanies this protocol.   
  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349695] patient safety or study data integrity will be immediately reported 
to the PI [INVESTIGATOR_1238] P M. T he Safety Officer  will be informed within 5 business days of study staff  becoming 
aware of a protocol deviation impacting patient safety or study data integrity . 
Staff will report all other protocol deviations . The KPWHRI IRB will be notified of deviations per reporting 
requirements . The NI A program director and Safety Officer  will review protocol deviations in the regular  
data reports . 
Events not considered protocol deviation s: Due to the pragmatic aspects of the study, t he failure of a 
provider or patient  to adhere to the protocol (e.g., not responding to request for information on a 
patient , not completing training ), are not considered protocol deviation s. These uncontrolled and 
expected events are of scientific interest due to the pragmatic nature of the study.   
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349696]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 10 ETHICS /PROTECTION  OF HUMAN SUBJECTS  
10.[ADDRESS_349697]  
The investigator will ensure that this research study is conducted in full conformity with the principles 
set forth in The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects 
of Research , as drafted by [CONTACT_286731] (April 18, 1979) and codified in 45 CFR Part 46 and/or the ICH E6 .  
10.[ADDRESS_349698] been tested and demonstrated effective elsewhere. No medications or other 
treatments are withheld or delayed. Prescribers are not advised to stop antipsychotic medications and 
remain free to exercise their own clinical judgment.  
10.2.1  Potential Risks  
One component of the skills training is to brainstorm strategies for reducing problem behaviors. For 
example, PLWD may become oppositional/defiant when asked to get dressed or bathe. This 
brainstorming process involves some trial -and-error and it is possib le that caregivers, with the best of 
intentions, may make problem behaviors temporarily worse as they experiment with their personalized 
strategies (A -B-C problem solving plan). This experience may be distressing and/or frustrating for both 
caregiver and P LWD .  
10.2.[ADDRESS_349699] participant confidentiality.  This includes the following:  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349700]  2024 
 ________________________________ ________________________________ ________________________________ ________   
 
 ________________________________ ________________________________ ____________________________   
 • All project data will be maintained on secure, password protected servers at clinical sites .  Only 
project staff need ing this information for their work will have access.  Members of the study 
team include Epic programmers from the delivery system ;  
• Participants will be identified using only subject ID  in any study analytic database(s) at each site ; 
• The protocol, documentation, data and all other identifying information will be held in strict 
confidence.  No information about the project will be released without prior approval of NIA.  
Authorized representatives of the NIA may inspect records, as needed.  
10.[ADDRESS_349701] no plans to retain identifiable information beyond this period.  If this plan changes, we will 
obtain appropriate IRB approval.  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349702]  
unless consent to retain these files is granted by [CONTACT_1201].  Following this time, no other records will be 
destro yed without the consent of NI A. It is the responsibility of NIA to inform the investigator when 
these documents no longer need to be retained . 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349703] a long history of sharing data with investigators locally and at other institutions and 
strongly support NIA’s effort to promote data sharing of results of publicly funded research to scientists 
in the US and elsewhere, with due respect for confidentiality and privacy. Our success supporting these 
projects is built on the understanding that effective data sharing m eans providing more than just data – 
it means offering programmatic and scientific support through an iterative process tailored to the needs 
of our external collaborators to help them understand and appropriately interpret data. Our data 
sharing philosoph y ensures the highest quality science while safeguarding the protection of data on 
STAR -VTF participants.  
 
12.[ADDRESS_349704] from the STAR -VTF team to support ancillary studies, collaborative meta -analyses, and external 
studies.  
Below we describe how we meet the five elements of NIA’s Guidance on Data Sharing. (25) 
 
12.2.1  Access - STAR -VTF Repository and Data Sharing Capacity  
We will make completely de -identified study data available on the National Archive of Computerized 
Data on Aging (NACDA) (26) following the Guide to Social Science Data Preparation and Archiving (27). 
We will transform SAS files into comma delimited text files so that the data can be used in a variety of 
statistical software packages.  
Each participant will have a unique study identification number linking tables for demographic data, 
item and total scores for standardized instruments, healthcare utilization, and pharmacy utilization. All 
dates will be transformed to “days relative to ra ndomization”. Cost data will be standardized to the 
Medicare fee -for-service fee schedule to protect financial data.  
We will also publish a data dictionary providing metadata descriptions in accompanying excel and pdf 
formats. Each variable will have a unique name, English language description, and description of its type 
(string, numeric) and length.  
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349705] to make sure that 
confidentiality is maintained. We will build on KPWHRI ’s existing secure data architecture and 
management systems to accommodate new data. When data are transferred NACDA, the PI [INVESTIGATOR_286717]. Prior to transfer from KPWHRI, a dedicated 
programmer and biostatistician pair with knowledge of the data will pre -review files to ensure 
compliance with regulations, alignment of data elements with permissions, and use of stra tegies to 
mitigate re -identification risk. Structured data extracted from source data will be transferred as either 
comma delimited text or SAS files.  
Unique identification numbers are assigned to all participants. Only the PI [INVESTIGATOR_286718]'s actual identification on an as -needed basis. All data collected for 
analytic purposes will be filed separately from clinical information, which may include participant 
names. Participant privacy and confidentiality will be protected through the creation of limited data sets 
and, where possible, data sets that are de -identified in accordance with the HIPAA Privacy Rule. Data 
will be transferred via KPWHRI’s web -based secure file transfer (SFT) application, which uses the [ADDRESS_349706] staff can access identifiable data. EHR data from KPWA systems 
and research data from other Cores will be stored in the KPWA Data Warehouse with unique 
anonymous encrypted identifiers that cannot be linked to KPWA ide ntifiers without specific 
programming. Data handling procedures will be clearly documented and comply with KPWA guidelines 
for data storage, transfer, and destruction.  
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349707] (EHR) data from KPWHRI’s instance of Clarity, or study dat a collected via REDCap will undergo 
comprehensive quality assurance to: (1) confirm that values fall within valid ranges and are internally 
consistent with related variables; (2) quantify levels of missing responses, accounting for complex skip 
patterns wh en relevant; and, (3) visualize temporal patterns in data elements to uncover unexpected 
trends, for instance from ICD -[ADDRESS_349708].  
 
 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349709], Sorvillo F, Kuo T. Burden of Alzheimer's disease -related mortality in 
the [LOCATION_002], 1999 -2008. J Am Geriatr Soc. 2012;60(8):1509 -14. Epub 2012/08/07.  
2. Association As. 2014 Alzheimer's Disease Facts and Figures. Alzheimer's & dementia : the journal 
of the Alzheimer's Association. 2014;10(2):67.  
3. Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the [LOCATION_002] (2010 -2050) 
estimated using the 2010 census. Neurology. 2013;80(19):1778 -83. Epub 2013/02/08.  
4. Weuve J, Hebert LE, Scherr PA, Evans DA. Deaths in the [LOCATION_002] among persons with 
Alzheimer's disease (2010 -2050). Alzheimer's & dementia : the journal of the Alzheimer's 
Association. 2014;10(2):e40 -6. Epub 2014/04/05.  
5. Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, et al. Risk of death in 
elderly users of conventional vs. atypi[INVESTIGATOR_16703]. N Engl J Med. 
2005;353(22):2335 -41. Epub 2005/12/02.  
6. Association AP. Choosing Wisely: Five Things Physicians and Patients Should Question. Available 
from: http://www.choosingwisely.org/doctor -patient -lists/american -psychiatric -association/ . 
7. Society AG. Choosing Wisely: Five Things Physicians and Patients Should Question.  
8. Aging Ao. Managing Difficult Behaviors: A Standardized Intervention to Help Family Caregivers 
(STAR -C): An Evidence -Based Intervention for Alzheimer's and Dementia Care.  
9. Teri L, McCurry SM, Logsdon R, Gibbons LE. Training community consultants to help family 
members improve dementia care: a randomized controlled trial. Gerontologist. 2005;45(6):802 -
11. Epub 2005/12/06.  
10. Teri L, McCurry SM, Logsdon RG, Gibbons LE, Buchner DM, Larson EB. A randomized controlled 
clinical trial of the Seattle Protocol for Activity in older adults. J Am Geriatr Soc. 
2011;59(7):1188 -96. Epub 2011/07/02.  
11. Logsdon RG, McCurry SM, Teri L. A home health care approach to exercise for persons with 
Alzheimer's disease. Care Manag J. 2005;6(2):90 -7. Epub 2006/03/21.  
12. Logsdon RG, McCurry SM, Teri L. STAR -Caregivers: a community -based approach for teaching 
family caregivers to use behavioral strategies to reduce affective disturbances in persons with 
dementia. Alzheimers Care Q. 2005;6(2):[ADDRESS_349710] of 
multicomponent interventions on caregiver burden and depression: the REACH multisite 
initiative at 6 -month follow -up. Psychol Aging. 2003;18(3):361 -74. Epub 200 3/10/02.  
14. O'Connor CM, Clemson L, Brodaty H, Jeon YH, Mioshi E, Gitlin LN. Use of the Tailored Activities 
Program to reduce neuropsychiatric behaviors in dementia: an Australian protocol for a 
randomized trial to evaluate its effectiveness. Int Psychogeriatr. 20 14;26(5):857 -69. Epub 
2014/02/11.  
15. Basu R, Hochhalter AK, Stevens AB. The Impact of the REACH II Intervention on Caregivers' 
Perceived Health. J Appl Gerontol. 2013. Epub 2014/03/22.  
16. Belle SH, Burgio L, Burns R, Coon D, Czaja SJ, Gallagher -Thompson D, et al. Enhancing the quality 
of life of dementia caregivers from different ethnic or racial groups: a randomized, controlled 
trial. Ann Intern Med. 2006;145(10):727 -38. Epub 2006/11/2 3. 
17. Mittelman MS, Bartels SJ. Translating research into practice: case study of a community -based 
dementia caregiver intervention. Health Aff (Millwood). 2014;33(4):587 -95. Epub 2014/04/09.  
18. McCurry SM, Teri L, Logsdon RG, La Fazia DM, Mead J, Stevens LA, et al. STAR -C MOVING FROM 
RCT TO TRANSLATION - INITIAL FINDINGS FROM OREGON AND BEYOND. Gerontologist. 
2012;52:296 -7. 
STAR Caregivers – Virtual Training and Follow -up Version 4 
Grant Number: [ADDRESS_349711]. Recruiting Community -Based Dementia Patients and Caregivers 
in a Nonpharmacologic Randomized Trial: What Works and How Much Does It Cost? J Appl 
Gerontol. 2014. Epub 2014/05/07.  
20. Teri L, Gibbons LE, McCurry SM, Logsdon RG, Buchner DM, Barlow WE, et al. Exercise plus 
behavioral management in patients with Alzheimer disease: a randomized controlled trial. 
JAMA. 2003;290(15):2015 -22. Epub 2003/10/16.  
21. Teri L, Huda P, Gibbons L, Young H, van Leynseele J. STAR: a dementia -specific training program 
for staff in assisted living residences. Gerontologist. 2005;45(5):686 -93. Epub 2005/10/04.  
22. Wagner EH, Ludman EJ, Aiello Bowles EJ, Penfold R, Reid RJ, Rutter CM, et al. Nurse navigators in 
early cancer care: a randomized, controlled trial. J Clin Oncol. 2014;32(1):12 -8. Epub 
2013/11/28.  
23. Rotnitzky A, Robins JM. Semiparametric regression estimation in the presence of dependent 
censoring. Biometrika. 1995;82(4):805 -20. 
24. Rubin DB. Multiple imputation for nonresponse in surveys. [LOCATION_001]: J Wiley & Sons; 1987.  
25. National Institute on Aging. NIA -specific funding policies. 2020 [cited 2020 April 19]; Available 
from: nia.nih.gov/research/grants -funding/nia -specific -funding -policies.  
26. NACDA - National Archive of Computerized Data on Aging.  [May 29, 2020.]; Available from: 
https://www.icpsr.umich.edu/web/pages/NACDA/deposit.html . 
27. Inter -university Consortium for Political and Social Research Inter -university Consortium for 
Political and Social Research. Guide to Social Science Data Preparation and Archiving. Best 
Practice Throughout the Data Lifecycle. 6th Edition.  [May 29, 202 0.]; Available from: 
https://www.icpsr.umich.edu/files/deposit/dataprep.pdf . 
 